Rakovina Therapeutics Inc.

Rakovina Therapeutics Inc.

ISIN: CA75103L3092

Rakovina Therapeutics Announces Appointment of Professor Petra Hamerlik to its Board of Directors

Chair of Translational Neuro-Oncology at the University of Manchester, previously a member of the Company's Scientific Advisory Board, elected at the 2026 Annual General Meeting VANCOUVER, British Columbia, September 10, 2026...
Read more >>

All NEWS OF Rakovina Therapeutics Inc.